Poul Sorensen nominated as significant Contributor to Canada’s Innovative Healthcare Industry

On May 7th, Bloom Burton & Co. announced that VAR2 Pharmaceuticals' co-founder and member of the Board, Prof. Poul Sorensen, is one of the three final nominees to the prestigious 2019 Bloom Burton Award, honouring individuals making the greatest contributions to Canada’s healthcare industry in the past years.

We are very proud of having Poul on the team!

Read more about the award here.